Bovine leukemia virus protease: Comparison with human T-lymphotropic virus and human immunodeficiency virus proteases

Journal of General Virology

Volumn 88, Issue 7, 2007, Pages 2052-2063

  Sperka, Tamás ^a   Miklóssy, Gabriella ^a   Tie, Yunfeng ^b   Bagossi, Péter ^a   Zahuczky, Gábor ^a   Boross, Péter ^a,b   Matúz, Krisztina ^a   Harrison, Robert W ^b   Weber, Irene T ^b   Tözsér, József ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,7 DIBENZYL 2,3,4,5,6,7 HEXAHYDRO 5,6 DIHYDROXY 1,3 BIS[4 (HYDROXYMETHYL)BENZYL] 2H 1,3 DIAZEPIN 2 ONE; AMINO ACID; AMPRENAVIR; ENZYME INHIBITOR; HBY 793; IB 268; IB 269; INDINAVIR; KH 164; LP 149; NELFINAVIR; OLIGOPEPTIDE; PROTEINASE; RITONAVIR; SAQUINAVIR; UK 88947; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; BOVINE LEUKEMIA VIRUS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE MUTATION; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; RETROVIRUS; SEQUENCE ANALYSIS; SPECIES COMPARISON; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; CATTLE; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA VIRUS, BOVINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; VIRAL PROTEINS;

ANIMALIA; BOVINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34347368981     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82704-0     Document Type: Article

References (40)

1. Altanerova, V., Holicova, D., Kucerova, L., Altaner, C., Lairmore, M. D. & Boris-Lawrie, K. (2004). Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits. Virology 329, 434-439.
2. Baboonian, C., Dalgleish, A., Bountiff, L., Gross, J., Oroszlan, S., Rickett, G., Smith-Burchnell, C., Troke, P. & Merson, J. (1991). HIV-1 proteinase is required for synthesis of pro-viral DNA. Biochem Biophys Res Commun 179, 17-24.
3. Bagossi, P., Kadas, J., Miklossy, G., Boross, P., Weber, I. T. & Tozser, J. (2004). Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases. J Virol Methods 119, 87-93.
4. Bagossi, P., Sperka, T., Feher, A., Kadas, J., Zahuczky, G., Miklossy, G., Boross, P. & Tozser, J. (2005). Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites. J Virol 79, 4213-4218.
5. Buehring, G. C., Philpott, S. M. & Choi, K. Y. (2003). Humans have antibodies reactive with bovine leukemia virus. AIDS Res Hum Retroviruses 19, 1105-1113.
6. Cameron, C. E., Grinde, B., Jacques, P., Jentoft, J., Leis, J., Wlodawer, A. & Weber, I. T. (1993). Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. J Biol Chem 268, 11711-11720.
7. De Clercq, E. (2004). Antiviral drugs in current clinical use. J Clin Virol 30, 115-133.
8. Fenyöfalvi, G., Bagossi, P., Copeland, T. D., Oroszlan, S., Boross, P. & Tözsér, J. (1999). Expression and characterization of human foamy virus proteinase. FEBS Lett 462, 397-401.
9. Fersht, A. R. (1985). Utilization of enzyme-substrate binding energy in catalysis. In Enzyme Structure and Mechanism, 2nd edn, pp. 311-317. New York: W. H. Freeman.
10. Griffiths, J. T., Phylip, L. H., Konvalinka, J., Strop, P., Gustchina, A., Wlodawer, A., Davenport, R. J., Briggs, R., Dunn, B. M. & Kay, J. (1992). Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites. Biochemistry 31, 5193-5200.
11. Grobelny, D., Wondrak, E. M., Galardy, R. E. & Oroszlan, S. (1990). Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus. Biochem Biophys Res Commun 169, 1111-1116.
12. Gustchina, A., Kervinen, J., Powell, D. J., Zdanov, A., Kay, J. & Wlodawer, A. (1996). Structure of equine infectious anemia virus proteinase complexed with an inhibitor. Protein Sci 5, 1453-1465.
13. Harrison, R. W. (1993). Stiffness and energy conservation in molecular dynamics: an improved integrator. J Comput Chem 14, 1112-1122.
14. Harrison, R. W. (2000). A self-assembling neural network for modeling polymers. J Math Chem 26, 125-138.
15. Hayakawa, T., Misumi, Y., Kobayashi, M., Yamamoto, Y. & Fujisawa, Y. (1992). Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease. Eur J Biochem 206, 919-925.
16. Herger, B. E., Mariani, V. L., Dennison, K. & Shuker, S. B. (2004). The 10 C-terminal residues of HTLV-I protease are not necessary for enzymatic activity. Biochem Biophys Res Commun 320, 1306-1308.
17. Kádas, J., Weber, I. T., Bagossi, P., Miklóssy, G., Boross, P., Oroszlan, S. & Tözsér, J. (2004). Narrow substrate specificity and sensitivity towards ligand binding site mutations of human T-cell leukemia virus type-1 protease. J Biol Chem 279, 27148-27157.
18. Leis, J., Baltimore, D., Bishop, J. M., Coffin, J., Fleissner, E., Goff, S. P., Oroszlan, S., Robinson, H., Skalka, A. M. & other authors (1988). Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 62, 1808-1809.
19. Lemey, P., Van Dooren, S. & Vandamme, A. M. (2005). Evolutionary dynamics of human retroviruses investigated through full-genome scanning. Mol Biol Evol 22, 942-951.
20. Li, M., Laco, G. S., Jaskolski, M., Rozycki, J., Alexandratos, J., Wlodawer, A. & Gustchina, A. (2005). Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design. Proc Natl Acad Sci U S A 102, 18332-18337.
21. Louis, J. M., Oroszlan, S. & Tözsér, J. (1999). Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase. J Biol Chem 274, 6660-6666.
22. Menendez-Arias, L., Gotte, D. & Oroszlan, S. (1993). Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme. Virology 196, 557-563.
23. Pettit, S. C., Simsic, J., Loeb, D. D., Everitt, L., Hutchison, C. A., III & Swanstrom, R. (1991). Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem 266, 14539-14547.
24. Powell, D. J., Bur, D., Wlodawer, A., Gustchina, A., Payne, S. L., Dunn, B. M. & Kay, J. (1996). Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus. Eur J Biochem 241, 664-674.
25. Precigoux, G., Geoffre, S., Leonard, R., Llido, S., Dautant, A., d'Estaintot, B. L., Picard, P., Menard, A., Guillemain, B. & Hospital, M. (1993). Modelling, synthesis and biological activity of a BLV proteinase, made of (only) 116 amino acids. FEBS Lett 326, 237-240.
26. Prejdova, J., Soucek, M. & Konvalinka, J. (2004). Determining and overcoming resistance to HIV protease inhibitors. Curr Drug Targets Infect Disord 4, 137-152.
27. Sayle, R. A. & Milner-White, E. J. (1995). RASMOL: biomolecular graphics for all. Trends Biochem Sci 20, 374.
28. Sheremata, W. A., Benedict, D., Squilacote, D. C., Sazant, A. & DeFreitas, E. (1993). High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy. Neurology 43, 2125-2129.
29. Tözsér, J. (1997). Specificity of retroviral proteinases based on substrates containing tyrosine and proline at the site of cleavage. Pathol Oncol Res 3, 142-146.
30. Tözsér, J. & Oroszlan, S. (2003). Proteolytic events of HIV-1 replication as targets for therapeutic intervention. Curr Pharm Des 9, 1803-1815.
31. Tözsér, J., Weber, I. T., Gustchina, A., Blaha, I., Copeland, T. D., Louis, J. M. & Oroszlan, S. (1992). Kinetic and modeling studies of S3-S3′ subsites of HIV proteinases. Biochemistry 31, 4793-4800.
32. Tözsér, J., Bagossi, P., Weber, I. T., Copeland, T. D. & Oroszlan, S. (1996). Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases. J Biol Chem 271, 6781-6788.
33. Tözsér, J., Zahuczky, G., Bagossi, P., Louis, J. M., Copeland, T. D., Oroszlan, S., Harrison, R. W. & Weber, I. T. (2000). Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases. Eur J Biochem 267, 6287-6295.
34. Weber, I. T. (1991). Modeling of structure of human immuno-deficiency virus-1 protease with substrate based on crystal structure of Rous sarcoma virus protease. Methods Enzymol 202, 727-741.
35. Willems, L., Kerkhofs, P., Attenelle, L., Burny, A., Portetelle, D. & Kettmann, R. (1997). The major homology region of bovine leukaemia virus p24gag is required for virus infectivity in vivo. J Gen Virol 78, 637-640.
36. Willems, L., Burny, A., Collete, D., Dangoisse, O., Dequiedt, F., Gatot, J. S., Kerkhofs, P., Lefebvre, L., Merezak, C. & other authors (2000). Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses 16, 1787-1795.
37. Wlodawer, A. & Gustchina, A. (2000). Structural and biochemical studies of retroviral proteases. Biochim Biophys Acta 1477, 16-34.
38. Wlodawer, A., Gustchina, A., Reshetnikova, L., Lubkowski, J., Zdanov, A., Hui, K. Y., Angleton, E. L., Farmerie, W. G., Goodenow, M. M. & other authors (1995). Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus. Nat Struct Biol 2, 480-488.
39. Wu, J., Adomat, J. M., Ridky, T. W., Louis, J. M., Leis, J., Harrison, R. W. & Weber, I. T. (1998). Structural basis for specificity of retroviral proteases. Biochemistry 37, 4518-4526.
40. Zahuczky, G., Boross, P., Bagossi, P., Emri, G., Copeland, T. D., Oroszlan, S., Louis, J. M. & Tözsér, J. (2000). Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase. Biochim Biophys Acta 1478, 1-8.